Apollo Endosurgery ROA 2006-2019 | APEN
Current and historical return on assets (ROA) values for Apollo Endosurgery (APEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Apollo Endosurgery ROA for the three months ending September 30, 2019 was -46.15%.
| Apollo Endosurgery ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2019-09-30 | $-0.04B | $0.08B | -49.52% |
| 2019-06-30 | $-0.04B | $0.08B | -48.34% |
| 2019-03-31 | $-0.04B | $0.08B | -44.81% |
| 2018-12-31 | $-0.05B | $0.07B | -47.79% |
| 2018-09-30 | $-0.04B | $0.10B | -33.33% |
| 2018-06-30 | $-0.03B | $0.11B | -27.65% |
| 2018-03-31 | $-0.03B | $0.10B | -26.34% |
| 2017-12-31 | $-0.03B | $0.11B | -27.14% |
| 2017-09-30 | $-0.03B | $0.11B | -33.76% |
| 2017-06-30 | $-0.04B | $0.09B | -51.25% |
| 2017-03-31 | $-0.04B | $0.09B | -81.19% |
| 2016-12-31 | $-0.04B | $0.10B | -133.33% |
| 2016-09-30 | $-0.06B | $0.00B | -180.95% |
| 2016-06-30 | $-0.05B | $0.01B | -150.00% |
| 2016-03-31 | $-0.04B | $0.01B | -116.67% |
| 2015-12-31 | $-0.04B | $0.11B | -98.01% |
| 2015-09-30 | $-0.01B | $0.01B | -83.58% |
| 2015-06-30 | $-0.02B | $0.02B | -75.00% |
| 2015-03-31 | $-0.02B | $0.02B | -77.11% |
| 2014-12-31 | $-0.02B | $0.02B | -72.73% |
| 2014-09-30 | $-0.01B | $0.03B | -53.01% |
| 2014-06-30 | $-0.01B | $0.02B | -59.46% |
| 2014-03-31 | $-0.01B | $0.02B | -42.11% |
| 2013-12-31 | $-0.01B | $0.02B | -31.17% |
| 2013-09-30 | $-0.01B | $0.02B | -31.82% |
| 2013-06-30 | $-0.01B | $0.02B | -22.47% |
| 2013-03-31 | $-0.01B | $0.02B | -22.22% |
| 2012-12-31 | $-0.00B | $0.03B | -13.33% |
| 2012-09-30 | $-0.01B | $0.02B | -24.69% |
| 2012-06-30 | $-0.00B | $0.02B | -14.63% |
| 2012-03-31 | $-0.00B | $0.02B | -4.88% |
| 2011-12-31 | $-0.00B | $0.02B | -19.51% |
| 2011-09-30 | $-0.00B | $0.02B | -4.55% |
| 2011-06-30 | $-0.01B | $0.02B | -27.40% |
| 2011-03-31 | $-0.01B | $0.02B | -48.28% |
| 2010-12-31 | $-0.00B | $0.02B | -36.36% |
| 2010-09-30 | $-0.00B | $0.01B | -42.86% |
| 2010-06-30 | $0.01B | $0.01B | 90.32% |
| 2010-03-31 | $0.00B | $0.01B | 50.00% |
| 2009-12-31 | $0.00B | $0.01B | 51.61% |
| 2009-09-30 | $0.00B | $0.01B | 25.00% |
| 2009-06-30 | $-0.01B | $0.01B | -90.32% |
| 2009-03-31 | $-0.01B | $0.01B | -74.07% |
| 2008-12-31 | $-0.01B | $0.01B | -169.23% |
| 2008-09-30 | $-0.01B | $0.01B | -200.00% |
| 2008-06-30 | $-0.02B | $0.00B | -206.45% |
| 2008-03-31 | $-0.02B | $0.01B | -167.44% |
| 2007-12-31 | $-0.02B | $0.01B | -168.42% |
| 2007-09-30 | $-0.01B | $0.01B | -180.65% |
| 2007-06-30 | $-0.01B | $0.02B | -173.91% |
| 2007-03-31 | $-0.01B | $0.00B | -215.38% |
| 2006-12-31 | $-0.01B | $0.00B | -117.65% |
| 2006-09-30 | $-0.01B | $0.00B | -114.29% |
| 2006-06-30 | $-0.01B | $0.01B | -117.65% |
| 2006-03-31 | $-0.00B | $0.01B | -133.33% |
| 2005-12-31 | $-0.00B | $0.01B | -200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.062B | $0.061B |
| Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $128.061B | 26.52 |
| Intuitive Surgical (ISRG) | United States | $67.145B | 52.77 |
| Edwards Lifesciences (EW) | United States | $48.117B | 43.69 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $22.046B | 14.92 |
| IDEXX Laboratories (IDXX) | United States | $21.607B | 52.26 |
| Olympus (OCPNY) | Japan | $19.851B | 149.08 |
| DexCom (DXCM) | United States | $18.489B | 165.57 |
| Teleflex (TFX) | United States | $16.502B | 33.50 |
| Sysmex ADR (SSMXY) | Japan | $14.482B | 38.98 |
| Hologic (HOLX) | United States | $14.263B | 21.80 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.163B | 0.00 |
| STERIS (STE) | Ireland | $13.028B | 28.77 |
| Varian Medical Systems (VAR) | United States | $12.895B | 30.57 |
| Masimo (MASI) | United States | $8.388B | 50.09 |
| ABIOMED (ABMD) | United States | $8.090B | 44.02 |
| Globus Medical (GMED) | United States | $5.745B | 35.45 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Penumbra (PEN) | United States | $5.563B | 181.04 |
| Integra LifeSciences Holdings (IART) | United States | $5.320B | 22.86 |
| Elekta AB (EKTAY) | Sweden | $4.737B | 36.47 |
| Wright Medical Group (WMGI) | Netherlands | $3.736B | 226.46 |
| LivaNova (LIVN) | United Kingdom | $3.712B | 26.73 |
| Tandem Diabetes Care (TNDM) | United States | $3.409B | 0.00 |
| Nevro (NVRO) | United States | $3.335B | 0.00 |
| Cantel Medical (CMD) | United States | $3.203B | 31.35 |
| Integer Holdings (ITGR) | United States | $2.607B | 17.85 |
| Nihon Kohden (NHNKY) | Japan | $2.374B | 23.89 |
| Glaukos (GKOS) | United States | $2.075B | 0.00 |
| Inogen (INGN) | United States | $1.577B | 49.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.544B | 30.39 |
| Veracyte (VCYT) | United States | $1.398B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.280B | 146.26 |
| Natus Medical (NTUS) | United States | $1.078B | 25.91 |
| Mesa Laboratories (MLAB) | United States | $1.074B | 39.83 |
| Silk Road Medical (SILK) | United States | $1.065B | 0.00 |
| OPKO Health (OPK) | United States | $1.018B | 0.00 |
| CryoLife (CRY) | United States | $0.977B | 100.23 |
| Luminex (LMNX) | United States | $0.975B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.883B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.866B | 28.78 |
| Pacific Biosciences Of California (PACB) | United States | $0.831B | 0.00 |
| Intersect ENT (XENT) | United States | $0.677B | 0.00 |
| AxoGen (AXGN) | United States | $0.670B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.644B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.589B | 21.16 |
| Quotient (QTNT) | Switzerland | $0.582B | 0.00 |
| Si-Bone (SIBN) | United States | $0.477B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.453B | 13.70 |
| Sientra (SIEN) | United States | $0.436B | 0.00 |
| ViewRay (VRAY) | United States | $0.420B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.403B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.311B | 0.00 |
| Stereotaxis (STXS) | United States | $0.311B | 0.00 |
| IRadimed (IRMD) | United States | $0.296B | 41.55 |
| Semler Scientific (SMLR) | United States | $0.294B | 40.91 |
| Accuray (ARAY) | United States | $0.253B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.243B | 67.80 |
| SeaSpine Holdings (SPNE) | United States | $0.213B | 0.00 |
| Fluidigm (FLDM) | United States | $0.211B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.181B | 49.10 |
| Restoration Robotics (VERO) | Canada | $0.145B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.134B | 35.46 |
| Spectral Diagnostics (EDTXF) | Canada | $0.132B | 0.00 |
| ConforMIS (CFMS) | United States | $0.106B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.083B | 0.00 |
| Vermillion (VRML) | United States | $0.072B | 0.00 |
| Electromed (ELMD) | United States | $0.068B | 24.24 |
| Sensus Healthcare (SRTS) | United States | $0.061B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.054B | 0.00 |
| TransEnterix (TRXC) | United States | $0.044B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.044B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.044B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.038B | 0.00 |
| Neovasc (NVCN) | Canada | $0.025B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.023B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.021B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.018B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 21.17 |
| DarioHealth (DRIO) | Israel | $0.015B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.015B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.014B | 0.00 |
| Avinger (AVGR) | United States | $0.013B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.012B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.009B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Dynatronics (DYNT) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.004B | 0.00 |
| InspireMD (NSPR) | Israel | $0.003B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.001B | 0.00 |
